By Emma Seppälä — 2013
Compassion research is at a tipping point: Overwhelming evidence suggests compassion is good for our health and good for the world.
Read on greatergood.berkeley.edu
CLEAR ALL
The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.
1
A single dose of psilocybin, a compound found in “magic mushrooms,” provides long-term relief of anxiety and depression in cancer patients, a new study finds.
3
The new research looked at cancer patients who took part in a study nearly five years ago.
Demand from patients seeking help for their mental illnesses has led to underground use in a way that parallels black markets in the AIDS pandemic. This underground use has been most perilous for people of color, who face greater stigma and legal risks due to the War on Drugs.
To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.
In the world’s largest study on psychedelics and the brain, a team of researchers from The Neuro (Montreal Neurological Institute-Hospital) and Department of Biomedical Engineering of McGill University, the Broad Institute at Harvard/MIT, SUNY Downstate Health Sciences University, and Mila—Quebec...
Psychedelic drugs like psilocybin are being tested to treat mental illness. They're also expanding our understanding about human consciousness.
Some experts view ketamine as a tool to unravel the biological causes of depression and, perhaps someday, cure it.
It seems that psychedelics do more than simply alter perception. According to the latest research from my colleagues and me, they change the structures of neurons themselves.
A new generation of research into psilocybin could change how we treat numerous mental health conditions.